Every number tells part of the story. We show you all of it.
A clinical trial lives or dies on its statistics, yet most teams only ever see them in pieces. The sample size calculation sits with one group, the interim analysis with another, and the safety data with a third. Each piece can look sound on its own while the full picture hides a problem: an underpowered endpoint, a drifting assumption, or a signal that only shows up when datasets are read side by side.
Those gaps are expensive. A flaw in the statistical design that surfaces late can mean a protocol amendment, months of delay, or a study that cannot answer the question it was built to ask. Regulators review the totality of the evidence, and they expect the analysis plan, the data, and the conclusions to hold together. Seeing everything at once, from the first design decision through the final readout, is how sponsors catch issues while they are still cheap to fix.
Most importantly, patients are behind every data point. A complete statistical view means fewer participants exposed to a trial that was never going to succeed, faster recognition of treatments that work, and earlier detection of the ones that cause harm. 360 Labs brings design, monitoring, and analysis into a single view so that every decision is made with the full evidence in hand.